首页> 外文期刊>Chemistry & biology >Isolation and Purification of a New Kalimantacin/ Batumin-Related Polyketide Antibiotic and Elucidation of Its Biosynthesis Gene Cluster
【24h】

Isolation and Purification of a New Kalimantacin/ Batumin-Related Polyketide Antibiotic and Elucidation of Its Biosynthesis Gene Cluster

机译:新型卡利米他滨/巴他汀相关的聚酮类抗生素的分离纯化及其生物合成基因簇的阐明

获取原文
获取原文并翻译 | 示例
           

摘要

Kal/bat, a polyketide, isolated to high purity (>95%) is characterized by strong and selective antibacterial activity against Staphylococcus species (minimum inhibitory concentration, 0.05 mg/mL), and no resistance was observed in strains already resistant to commonly used antibiotics. The kal/bat biosynthesis gene cluster was determined to a 62 kb genomic region of Pseudomonas fluorescens BCCM_ID9359. The kal/bat gene cluster consists of 16 open reading frames (ORF), encoding a hybrid PKS-NRPS system, extended with trans-acting tailoring functions. A full model for kal/bat biosynthesis is postulated and experimentally tested by gene inactivation, structural confirmation (using NMR spectroscopy), and complementation. The structural and microbiological study of biosynthetic kal/bat analogs revealed the importance of the carbamoyl group and 17-keto group for antibacterial activity. The mechanism of self-resistance lies within the production of an inactive intermediate, which is activated in a one-step enzymatic oxidation upon export. The genetic basis and biochemical elucidation of the biosynthesis pathway of this antibiotic will facilitate rational engineering for the design of novel structures with improved activities. This makes it a promising new therapeutic option to cope with multidrug-resistant clinical infections.
机译:Kal / bat,一种高纯度(> 95%)的聚酮化合物,其特征在于对葡萄球菌具有强而有选择性的抗菌活性(最低抑菌浓度,0.05 mg / mL),在已经对常用菌株产生抗药性的菌株中未观察到抗药性抗生素。确定kal / bat生物合成基因簇为荧光假单胞菌BCCM_ID9359的62kb基因组区域。 kal / bat基因簇由16个开放阅读框(ORF)组成,编码一个混合的PKS-NRPS系统,并扩展了反式剪裁功能。通过基因失活,结构确认(使用NMR光谱法)和互补作用,提出了Kal / bat生物合成的完整模型并进行了实验测试。生物合成的kal / bat类似物的结构和微生物学研究表明,氨基甲酰基和17-酮基对抗菌活性很重要。自抗性的机理在于无活性中间体的产生,该中间体在出口时以一步酶促氧化的方式被活化。这种抗生素的生物合成途径的遗传基础和生化方法的阐明,将有助于进行合理的工程设计,以设计具有改进活性的新型结构。这使其成为应对多药耐药性临床感染的有前途的新治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号